BI Asset Management Fondsmaeglerselskab’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.06M | Sell |
|
|||||
|
2025
Q2 | $2.25M | Buy |
|
|||||
|
2025
Q1 | $1.44M | Sell |
|
|||||
|
2024
Q4 | $2.77M | Buy |
|
|||||
|
2024
Q3 | $2.34M | Buy |
|
|||||
|
2024
Q2 | $1.11M | Buy |
|
|||||
|
2024
Q1 | $557K | Sell |
|
|||||
|
2023
Q4 | $721K | Buy |
|
|||||
|
2023
Q3 | $300K | Sell |
|
|||||
|
2023
Q2 | $420K | Sell |
|
|||||
|
2023
Q1 | $2.42M | Buy |
|
|||||
|
2022
Q4 | $1.34M | Buy |
|
|||||
|
2022
Q3 | $582K | Sell |
|
|||||
|
2022
Q2 | $457K | Buy |
|
|||||
|
2022
Q1 | $305K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $43K | Buy |
|